Lin‐Li Chang

723 total citations
33 papers, 542 citations indexed

About

Lin‐Li Chang is a scholar working on Surgery, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Lin‐Li Chang has authored 33 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Molecular Medicine and 8 papers in Molecular Biology. Recurrent topics in Lin‐Li Chang's work include Bladder and Urothelial Cancer Treatments (12 papers), Antibiotic Resistance in Bacteria (9 papers) and Enterobacteriaceae and Cronobacter Research (5 papers). Lin‐Li Chang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Antibiotic Resistance in Bacteria (9 papers) and Enterobacteriaceae and Cronobacter Research (5 papers). Lin‐Li Chang collaborates with scholars based in Taiwan and Czechia. Lin‐Li Chang's co-authors include Wen‐Jeng Wu, Hui‐Hui Lin, Hung‐Lung Ke, Chung‐Yu Chang, Chun‐Hsiung Huang, Po‐Liang Lu, Wen‐Ting Yeh, Yen‐Hsu Chen, Hsi-Hsun Lin and Chung‐Hsu Lai and has published in prestigious journals such as PLoS ONE, The FASEB Journal and The Journal of Urology.

In The Last Decade

Lin‐Li Chang

33 papers receiving 535 citations

Peers

Lin‐Li Chang
Comparison fields: 5 of 78
  • Molecular Biology 212
  • Surgery 201
  • Molecular Medicine 87
  • Endocrinology 80
  • Cancer Research 79
Replace Matthew G. Varga with:
Matthew G. Varga United States
Juha O. Grönroos Finland
Mary Lynch United States
Carles Saus Spain
Franziska Römmler Germany
Ruperto González‐Pérez Spain
Bertrand Bearzatto Belgium
Benjamin K. Billips United States
Aurélie Couturier-Maillard France
Jean-Christophe Beaudoin France
Matthew G. Varga United States View profile →
Citations per field, relative to Lin‐Li Chang
Lin‐Li Chang · 1×
Citations per year, relative to Lin‐Li Chang
Lin‐Li Chang · 1×

Countries citing papers authored by Lin‐Li Chang

Since Specialization
Citations

This map shows the geographic impact of Lin‐Li Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Li Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Li Chang more than expected).

Fields of papers citing papers by Lin‐Li Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Li Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Li Chang. The network helps show where Lin‐Li Chang may publish in the future.

Co-authorship network of co-authors of Lin‐Li Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Li Chang. A scholar is included among the top collaborators of Lin‐Li Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Li Chang. Lin‐Li Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 13
2 6
3 20
4 25
5 8
6
High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients.
11
7 25
8 23
9 26
10 35
11 16
12 24
13 10
14 22
15 23
16 18
17 33
18
Telomerase activity in human bladder tumors and bladder washing specimens.
8
19
Characterization of a new human transitional cell carcinoma cell line from the renal pelvis, RTCC-1/KMC.
8
20 5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026